Skip to content

Stress Management and Resiliency Training Following Acute Myocardial Infarction

Total-Body PET Imaging to Understand the Physiology of Stress, Inflammation, and Meditation Following a Heart Attack

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05415735
Enrollment
10
Registered
2022-06-13
Start date
2022-05-11
Completion date
2023-10-01
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Heart Attack

Brief summary

The goal of this pilot study is to use total body PET/CT imaging to examine the relationships between stress, amygdala activation, and arterial wall inflammation in participants before and after participating in a multi-modal stress reduction program.

Interventions

This is a multimodal mind-body program designed to teach participants a variety of different strategies to reduce their physiologic stress response.

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Concurrently enrolled in an observational study of patients who have had an acute myocardial infarction * Score on PSS-10 of 14 or greater during screening * Willing and able to access the internet to participate in the online SMART Program

Exclusion criteria

* Poorly controlled physical or mental health condition that would likely interfere with the ability to participate in SMART or ability to undergo PET scan * Current daily practice of meditation of 10 minutes or more per day

Design outcomes

Primary

MeasureTime frameDescription
Change in amygdala activationabout 10 weekschange in radiotracer uptake in the amygdala with FDG-PET imaging from before to after the SMART Program

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026